News - UF Innovate

Accelerate Client GreenTechnologies, LLC Awarded Small Business Innovation Research Phase I Funding from EPA

Accelerate client GreenTechnologies, LLC has received funding from the United States Environmental Protection Agency to develop technologies that will help protect human health and the environment.

President’s Office Announces $10.2 Million for Fourth Round of Strategic Funding Awardees

The UF President's Office recently announced a fourth round of strategic funding to grow UF's research capabilities in critical areas of AI, space exploration, healthcare, and more.

Is the Calabaza the Next Great Gourd for Growers in the Southeastern U.S.? UF/IFAS Is One Step Closer to a Choice Cultivar

Researchers at the University of Florida's Institute of Food and Agricultural Sciences are establishing the Calabaza as a choice cultivar in the Southeast. Geoffrey Meru, a UF/IFAS vegetable geneticist and his team at the UF/IFAS Tropical Research and Education Center in Homestead have laid the groundwork to make Calabaza a choice cultivar for growers in the southeast. They hope to release the powerful potential of the calabaza that packs a punch for its nutritional content, adaptability and sustainability.

University of Florida Announces the 2023 National Academy of Inventors Fellows

The National Academy of Inventors has named two UF researchers to their 2023 class of distinguished academic inventors.

UF Strategic Investment Will Advance Research Software Engineering and Enable Leading-Edge Data Modeling

UF will be forming a software developer group to assist investigators with highly technical tasks to increase research efficiency and elevate the use of advanced technology like UF's HiPerGator supercomputer.

Tech Tuesday – etectRx

Tech Tuesday with Eric Buffkin, CEO of etectRx, as he outlines the company's newest partnership with the Village in Gainesville to improve incontinence monitoring, elevate care for seniors, and alleviate pressure on staff.

Atsena Therapeutics Announces Positive 12-Month Safety and Efficacy Data From Ongoing Phase I/II Clinical Trial To Treat Leber Congenital Amaurosis

Atsena Therapeutics announced positive results in their 12-month safety and efficacy data from the ongoing Phase I/II trial of ATSN-101, the company’s investigational gene therapy for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1). At 12 months post-treatment, ATSN-101 has conferred clinically meaningful improvements in vision at the highest dose with no serious treatment-emergent adverse events.

The University of Florida, Concept Companies, and Trimark Properties Join Forces To Make Gainesville’s Innovation District a Major Economic Hub

The UF Board of Trustees is partnering with Concept Companies and Trimark Properties to expand Gainesville's Innovation District with 13 acres of land in the development pipeline. The plan aims to boost the Innovation District's presence as a place for new ideas and thriving new companies. From AI to BioTech, these new spaces will allow innovation to thrive in Gainesville and across the UF campus.

Tech Tuesday – Adam Veige

In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Adam Veige, professor in the UF Department of Chemistry and winner of an Invention of the Year award at StandingInnOvation 2023. He explains his invention, a cyclic version of polypropylene, which he aims to commercialize.

University of Florida Ranks Among Top 25 Universities With $1.085 Billion in 2022 Research Expenditures

The University of Florida’s $1.085 billion in research expenditures in fiscal year 2022 placed it 25th among all U.S. universities, up from 27th in 2021, in a new national ranking of R&D spending by the National Science Foundation. UF was 15th among public universities, up from 16th.

UF News